Radiopharmaceutical Market

Radiopharmaceutical Market Research Report: Forecast up to 2024
Radiopharmaceutical Market: Snapshot
The global market for radiopharmaceuticals is poised for steady growth in the coming years,
driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as
cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million
patients undergo treatment procedures for these diseases each year and this will continue to boost
the demand for radiopharmaceuticals.
According to the Nuclear Energy Institute, radioisotopes are essential for biomedical research in
order to cure AIDS, cancer, and Alzheimer’s disease. The World Nuclear Association states that
around 10,000 hospitals across the world use radioisotopes in medicines and 90% of this is
dedicated toward disease diagnosis.
The global radiopharmaceutical market was valued at US$4.7 bn in 2015 and is estimated to reach
US$7.4 bn by 2024, expanding at a CAGR of 5.3% from 2016 to 2024.
Growing Incidence of Cancer Driving Demand for Most Radioisotopes
Based on radioisotope, the technetium-99 segment led the global radiopharmaceuticals market,
accounting for a share of 50.3% in 2015. This can be attributed to the high availability of
technetium-99 from molybdenum-99, which is generated through the decay of uranium radioactive
raw material inside the sources.
The 18F radioisotope segment is expected to gain market share during the forecast period due to the
increase in demand for cyclotron-based radioisotopes for nuclear medicine and the advancement of
technological systems such as PET and SPECT. The demand for other radioisotopes such as
lutetium-177, rubidium-87, and gallium-62 is also high due to the rising demand for radioisotopes
for cancer treatment, the surge in the prevalence of cardiovascular diseases, and the detection of
other infectious diseases. Based on application, oncology took the lead owing to the growing use of
various radioisotopes in the treatment of different cancers.
Radiopharmaceutical products are used by various end users such as hospitals, ambulatory surgical

centers, and diagnostic centers. Hospitals formed the leading segment of the market in terms of
revenue in 2015 due to the growing usage of radiopharmaceutical. This can be attributed to
technological advancements in various systems to cure cancer patients and the rise in favorable
government reimbursement policies to help patients recover their costs and provide precaution
against biohazards. The ambulatory surgical centers and diagnostic centers segments are expected to
gain market share by 2024 due to the introduction of advanced imaging technologies such as
SPECT and PET.
This exhaustive report includes a 360° view of the Radiopharmaceutical Market. Browse
through this 246-page report to know what factors will shape the market during the period
2016-2024
http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
Developing Regions to Witness Steady Growth despite Small Share in Global Market
The global radiopharmaceuticals market has been segmented into North America, Latin America,
Asia Pacific, Europe, and the Middle East and Africa. North America led the radiopharmaceuticals
market in 2015 in terms of revenue, with the U.S. emerging as the most prominent contributor to the
radiopharmaceuticals market in North America. This can be attributed to the existence of several
large nuclear reactors such as NRU, which accounts for a 30% to 40% share in the Mo-99 supply
for the global production of nuclear medicine.
Europe is also expected to account for a significant share by 2024 due to the increase in the number
of cyclotron installations for the production of radioisotopes used in the treatment of cancer and
other diseases.
The Middle East and Africa is projected to account for a small share in the global market by 2024.
However, growth in this market is likely to be attributed to the introduction of cyclotrons by the
IBA Group and the setting up of new nuclear reactors such as ETRR-2 in South Africa for the
production of radioisotopes.
Latin America is estimated to account for a meager share by the end of the forecast period.
However, it continues to be driven by the increase in domestic collaborations with foreign
radiopharmaceutical companies and major suppliers of radioactive raw materials and the
establishment of hospitals and ambulatory surgical centers for cancer patients.
Prominent players operating in the radiopharmaceutical market include Advanced Accelerator
Applications (AAA), Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Lantheus
Holdings, Inc., Mallinckrodt plc., Nordion, Inc., Siemens Healthineers, and Positron Corporation.

Request a brochure of this report to know what opportunities will emerge in the rapidly
evolving Radiopharmaceutical Market during 2016- 2024
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants, use proprietary data sources and various
tools and techniques to gather, and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and
technology. These reports provide in-depth analysis and deep segmentation to possible micro levels.
With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide
clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com